Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Solid Tumors × Bevacizumab × Clear all

Phase

Phase 1 6 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 32 Glioblastoma 23 Carcinoma, Non-Small-Cell Lung 19 Ovarian Neoplasms 13 Brain Neoplasms 12 Pancreatic Neoplasms 11 Glioma 10 Carcinoma, Renal Cell 10 Breast Neoplasms 10 Neoplasms 9 Carcinoma, Hepatocellular 9 Neoplasm Metastasis 8 Colonic Neoplasms 8 Astrocytoma 8 Melanoma 7 Uterine Cervical Neoplasms 6 Rectal Neoplasms 6 Gliosarcoma 6 Lung Neoplasms 5 Fallopian Tube Neoplasms 5 Endometrial Neoplasms 5 Colorectal Cancer Metastatic 5 Advanced Solid Tumors 5 Stomach Neoplasms 4 Oligodendroglioma 4 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Liver Neoplasms 3 Diffuse Intrinsic Pontine Glioma 3 Advanced Solid Tumor 3

Interventions

pembrolizumab 4 Nivolumab 2 Injections 2 Docetaxel 2 taxane 1 pazopanib 1 palbociclib 1 lenvatinib 1 demplatin pegraglumer 1 cobimetinib 1 birinapant 1 Topotecan 1 Tablets 1 ODM-207 1 Infusions, Intravenous 1 HLA-A*24:02 antigen 1 Gemcitabine 1 E-3810 1 CB-839 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05101070 2026-03-18

aCCeleR8-001

Shionogi Inc.

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡